Every Alternative to GobyMeds
GobyMeds charges $99 a month for semaglutide and tirzepatide. None of the 12 sellers compared here costs meaningfully less; the closest is Trimi Health at $99. All 12 score higher than GobyMeds' 8.3/10, and Trimi Health rates highest at 9.4.
Baseline for every row below
GobyMeds
Where it fits: Moving between compounded and brand without changing seller
GobyMeds advertises $93 for month one. Every row below compares against the standing $99/mo you pay from month two, not the introductory rate.
Editor's picks
Top alternatives to GobyMeds
No insurance needed
vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
- Top pick9.4Get started →
From
$99/mo
- 9.0Get started →
From
$99/mo
- 9.0Get started →
From
$99/mo
- 9.0Get started →
From
$99/mo
| Provider | From | Save vs GobyMeds | |
|---|---|---|---|
9.4Trimi HealthTop pick | $99/mo | — | Get started → |
9.0CoreAge Rx | $99/mo | — | Get started → |
9.0bmiMD | $99/mo | — | Get started → |
9.0Live Vital | $99/mo | — | Get started → |
How GobyMeds compares on the four things that matter
- Monthly price. GobyMeds: $99 a month, and no alternative here is meaningfully cheaper. What the higher-priced ones add is in the table.
- Medication. GobyMeds sells compounded and brand-name semaglutide and tirzepatide. If you would rather not inject, He & She MD, Pepti and Alan Meds offer an oral option.
- Where it ships. GobyMeds does not publish the states it serves. Trimi Health, bmiMD and CoreAge Rx say they serve all 50.
- What the price includes. GobyMeds' price covers the medication, clinician visits and shipping. He & She MD and Shapely also include coaching.
The rest of the category
Everything else we track in this category, and how each one prices against GobyMeds.
- He & She MDStarting below a standard dose, with microdose tiers$99/mo9.2/10No monthly saving to showGo to site
- PeptiBloodwork inside the $99/month rather than billed on top$99/mo9.0/10No monthly saving to showGo to site
- Vitara RXSemaglutide at $99/month, 48% below the typical price$99/mo9.0/10No monthly saving to showGo to site
- Cora HealthSemaglutide at $99/month, 49% below the typical price$99/mo8.9/10No monthly saving to showGo to site
- MyFastRxSemaglutide at $99/month, 48% below the typical price$99/mo8.9/10No monthly saving to showGo to site
- Fresh Day MedsSemaglutide at $99/month, 48% below the typical price$99/mo8.8/10No monthly saving to showGo to site
- Alan MedsSemaglutide at $99/month, 48% below the typical price$99/mo8.4/10No monthly saving to showGo to site
- ShapelySemaglutide at $99/month, 48% below the typical price$99/mo8.4/10No monthly saving to showGo to site
| Seller | Score | From | vs GobyMeds | Site |
|---|---|---|---|---|
| He & She MDStarting below a standard dose, with microdose tiers | 9.2/10 | $99/mo | — | Go to site |
| PeptiBloodwork inside the $99/month rather than billed on top | 9.0/10 | $99/mo | — | Go to site |
| Vitara RXSemaglutide at $99/month, 48% below the typical price | 9.0/10 | $99/mo | — | Go to site |
| Cora HealthSemaglutide at $99/month, 49% below the typical price | 8.9/10 | $99/mo | — | Go to site |
| MyFastRxSemaglutide at $99/month, 48% below the typical price | 8.9/10 | $99/mo | — | Go to site |
| Fresh Day MedsSemaglutide at $99/month, 48% below the typical price | 8.8/10 | $99/mo | — | Go to site |
| Alan MedsSemaglutide at $99/month, 48% below the typical price | 8.4/10 | $99/mo | — | Go to site |
| ShapelySemaglutide at $99/month, 48% below the typical price | 8.4/10 | $99/mo | — | Go to site |
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory